IMBRUVICA® (ibrutinib) Receives 11th FDA Approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
| AbbVie (NYSE: ABBV) | Delayed: 266.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.69 | 52 Week High | $68.12 | |||
| Open | $266.69 | 52 Week Low | $50.71 | |||
| Day High | $266.69 | P/E | 57.85 | |||
| Day Low | $266.69 | EPS | $4.61 | |||
| Volume | 2,127 | |||||
